Bain Capital Life Sciences Investors, LLC Q4 2019 Filing
Filed February 14, 2020
Portfolio Value
$670.5B
Holdings
10
Report Date
Q4 2019
Filing Type
13F-HR
All Holdings (10 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | SWTXSPRINGWORKS THERAPEUTICS INC | 7,281,307 | $280.3B | 41.80% | |
| 2 | —CONSTELLATION PHARMACEUTICALS INC. | 2,823,529 | $133.0B | 19.84% | |
| 3 | —DICERNA PHARMACEUTICALS INC | 4,080,237 | $89.9B | 13.41% | |
| 4 | DVAXDYNAVAX TECHNOLOGIES CORP. | 8,452,235 | $48.3B | 7.21% | |
| 5 | REPLREPLIMUNE GROUP INC | 2,838,968 | $40.7B | 6.08% | |
| 6 | YB4PSAVARA INC | 5,128,593 | $23.0B | 3.43% | |
| 7 | ASNSUSDX4 PHARMACEUTICALS INC | 1,648,485 | $17.6B | 2.63% | |
| 8 | SLDBSOLID BIOSCIENCES INC | 3,871,164 | $17.2B | 2.57% | |
| 9 | —MARINUS PHARMACEUTICALS INC | 5,942,735 | $12.8B | 1.91% | |
| 10 | —APTINYX INC | 2,225,092 | $7.6B | 1.13% |